Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

27.28 +0.42 (+1.56%)

Delayed Quote Updated: 4:00 PM EDT, Oct 30, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Viking Therapeutics, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

34 35 Next >

Viking Therapeutics Stock Pops But Struggles to Hold Gains

April 16, 2025

VKTX stock shot higher after announcing a phase 3 trial for its GLP-1 drug candidate; but investors are concerned about a lack of support in Washington

Via MarketBeat

Will Pfizer Approach Viking Therapeutics With A Buyout Proposa ↗

April 15, 2025

Investors are running into Viking Therapeutics this week after an incident of drug-induced liver injury pushed Pfizer into terminating the development of its weight-loss pill.

Via Talk Markets

Topics Stocks / Equities

Down 71%, Should You Buy the Dip on Viking Therapeutics Stock? ↗

April 15, 2025

Via The Motley Fool

Wall Street Sees Pfizer's Weight-Loss Pill Exit As A Win For 2 Smaller Biotech Firms: Retail Turns Bullish ↗

April 15, 2025

Investors are now considering the possibility of Pfizer acquiring either of these companies as it looks for external candidates.

Via Stocktwits

Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today ↗

April 14, 2025

Pfizer bows, but is not entirely out of the GLP-1 race.

Via The Motley Fool

What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday? ↗

April 14, 2025

Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesity drug competition.

Via Benzinga

Third Harmonic Bio, Apple, Dell And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

April 14, 2025

Via Benzinga

Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury ↗

April 14, 2025

The company is continuing to test a daily pill that blocks GIPR.

Via Investor's Business Daily

3 Magnificent Stocks That Could Double or More by 2030 ↗

April 12, 2025

Via The Motley Fool

Will Viking Therapeutics Be a Top Healthcare Stock in 10 Years? ↗

April 10, 2025

Via The Motley Fool

The Smartest Biotech Stocks to Buy With $50 ↗

April 03, 2025

Via The Motley Fool

Viking Therapeutics, Down 40%, Just Reached a New Milestone. Is the Stock a Buy Now? ↗

April 02, 2025

Via The Motley Fool

Which Healthcare Stock Is the Best Buy Right Now?

March 31, 2025

Healthcare stocks provide a combination of upstarts with a high risk, high reward proposition to established firms that can be a defensive maneuver.

Via MarketBeat

Viking Therapeutics Skids Despite 'Rapid' Enrollment In Obesity Pill Study ↗

March 26, 2025

The "rapid" enrollment suggests there's still huge interest in the company's approach to obesity treatment.

Via Investor's Business Daily

Motley Fool 2025 March Market Cap Showdown Championship ↗

March 24, 2025

Via The Motley Fool

Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly ↗

March 23, 2025

Via The Motley Fool

MarketBeat Week in Review – 03/17 - 03/21

March 22, 2025

Stocks gained after the Fed meeting but drifted lower after disappointing guidance from FedEx; next week's inflation data is unlikely to provide needed clarity

Via MarketBeat

Topics Economy Government World Trade

10 Health Care Stocks Whale Activity In Today's Session ↗

March 21, 2025

Via Benzinga

1 Biotech Stock Down 52% That Could Soar by 233%, According to Wall Street ↗

March 20, 2025

Via The Motley Fool

Down 65% From Its 52-Week High, Is Viking Therapeutics Stock a Bargain Buy? ↗

March 19, 2025

Via The Motley Fool

Is Novo Nordisk a No-Brainer Buy After It Dropped 40%? ↗

March 19, 2025

Via The Motley Fool

Is Viking Therapeutics the Next Blockbuster GLP-1 Stock?

March 18, 2025

Viking Therapeutic may have a GLP-1 blockbuster on their hands with VK2735 as it produces weight loss at 5X the speed of Novo Nordisk's Wegovy GLP-1 drug.

Via MarketBeat

Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped ↗

March 12, 2025

Ignore the noise in GLP-1 stocks. Find the best value instead.

Via The Motley Fool

10 Health Care Stocks Whale Activity In Today's Session ↗

March 11, 2025

Via Benzinga

Viking Therapeutics Just Inked A $150 Million Manufacturing Deal. Here's Why Shares Crumbled. ↗

March 11, 2025

The company will pay CordenPharma $150 million over three years in a manufacturing deal.

Via Investor's Business Daily

Is Eli Lilly Stock a Buy? ↗

March 11, 2025

Via The Motley Fool

The State of Weight Loss Drugs ↗

March 10, 2025

Via The Motley Fool

BJ's Wholesale Club Posts Better-Than-Expected Earnings, Joins Burlington Stores, Veeva Systems And Other Big Stocks Moving Higher On Thursday ↗

March 06, 2025

Via Benzinga

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion. ↗

March 03, 2025

This is the drugmaker's first foray into weight-loss drugs. And it's not focusing on GLP-1.

Via Investor's Business Daily

MarketBeat Week in Review – 02/24 - 02/28

March 01, 2025

Stocks tried to stage a weak rally to close the week but the short-term outlook will continue to be dictated by the uncertainty that is creating volatility

Via MarketBeat

Topics Economy World Trade

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

34 35 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.